Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India-Reference-Cited by-同舟云学术

Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India

Published:2018-03-07 Issue:8 Volume:65 Page:e27028
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Narula Gaurav¹^ORCID,Pradhan Nirmalaya D.¹,Arora Brijesh¹,Banavali Sripad D.¹

Affiliation:

1. Pediatric Hematolymphoid Disease Management Group; Department of Medical Oncology; Tata Memorial Center; Mumbai India

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease as related manifestations of a single nosologic entity;Lichtenstein;AMA Arch Pathol,1953

2. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis;Ladisch;Med Pediatr Oncol,1994

3. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis;Gadner;J Pediatr,2001

4. Treatment strategy for disseminated Langerhans cell histiocytosis;Gadner;Med Pediatr Oncol,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High risk Langerhans cell histiocytosis in children: the role of salvage in improving the outcome. A single center experience;Orphanet Journal of Rare Diseases;2024-06-24

2. High Risk Langerhans Cell Histiocytosis in Children: The role of salvage in improving the outcome. A single center experience.;2023-12-06

3. Early response to chemotherapy in children with Langerhans cell histiocytosis predicts long-term disease-free survival;Indian Journal of Cancer;2023-01

4. Clinical outcomes and screening for organ involvement in pediatric Langerhans cell histiocytosis in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group;International Journal of Hematology;2022-01-31

5. Incidence, Clinical Features, and Outcomes of Langerhans Cell Histiocytosis in the United States;Journal of Pediatric Hematology/Oncology;2022-01-26